Testing the safety of ALZ-507 in healthy older adults
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 75 years old
- You are generally healthy, with no major heart, lung, kidney, liver, or other chronic conditions
- You have a body mass index (BMI) between 18 and 35, and weigh at least 50 kg (about 110 pounds)
- You have normal blood pressure and heart rate, and no heart rhythm problems
- You have not taken the study drug ALZ-507 or similar drugs (ALZ-801 or tramiprosate) in the past
- You have not used drugs or alcohol heavily in the last 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease. It aims to see if the drug is safe and can help slow memory decline.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
This trial tests an investigational drug called ALN-5288 for people with Alzheimer's disease. It aims to see if the drug is safe and how it affects the body.
This study tests a new oral investigational drug in healthy adults to see how safe it is and how the body handles it. It is an early-phase trial that helps determine the right dose and check for side effects.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.